MG
IMGN

Michael Gelband’s Immunogen Inc IMGN Stock Holding History

Michael Gelband’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-38,733
Closed -$615K – 2173
2023
Q3 		$615K Buy
+38,733
New +$644K 0.01% 1166
2023
Q2 		– Sell
-31,268
Closed -$120K – 2349
2023
Q1 		$120K Buy
+31,268
New +$133K ﹤0.01% 1621
2022
Q4 		– Sell
-360,717
Closed -$1.72M – 2266
2022
Q3 		$1.72M Buy
360,717
+209,281
+138% +$1.1M 0.02% 868
2022
Q2 		$681K Buy
151,436
+731
+0.5% +$3.18K 0.01% 1242
2022
Q1 		$717K Buy
150,705
+108,428
+256% +$600K 0.01% 1340
2021
Q4 		$314K Sell
42,277
-253,725
-86% -$1.58M ﹤0.01% 1643
2021
Q3 		$1.68M Buy
296,002
+179,536
+154% +$1.04M 0.02% 795
2021
Q2 		$768K Buy
116,466
+20,326
+21% +$142K 0.01% 1129
2021
Q1 		$779K Buy
96,140
+75,940
+376% +$620K 0.01% 1069
2020
Q4 		$130K Sell
20,200
-58,813
-74% -$343K ﹤0.01% 1802
2020
Q3 		$284K Buy
79,013
+68,646
+662% +$277K 0.01% 1318
2020
Q2 		$48K Sell
10,367
-33,271
-76% -$142K ﹤0.01% 1685
2020
Q1 		$149K Buy
+43,638
New +$191K 0.01% 839

Other funds holding IMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Michael Gelband's IMGN Position: Q4 2023 in Review

Michael Gelband sold out of Immunogen Inc (IMGN) in Q4 2023, closing a stake of 38,733 shares — an estimated $615K sold.

Michael Gelband first reported a position in IMGN in Q1 2020 and held it in 13 quarters. The position peaked at $1.72M in Q3 2022. 327 funds tracked by Wall St. Rank hold IMGN as of Q4 2023.

  • Michael Gelband reported no remaining Immunogen Inc position as of Q4 2023 after selling out during the quarter.
  • Michael Gelband sold 38,733 Immunogen Inc shares in Q4 2023, an estimated $615K.
  • Michael Gelband first reported a position in Immunogen Inc in Q1 2020 and held it in 13 quarters.
  • Michael Gelband's Immunogen Inc position peaked at $1.72M in Q3 2022.
  • 327 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2023.

Based on ExodusPoint Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.